Literature DB >> 15507989

Defining standards of care in maternal-fetal medicine.

Errol R Norwitz1, Mert O Bahtiyar, Baha M Sibai.   

Abstract

OBJECTIVE: The purpose of this study was to describe current practice patterns for 7 controversial topics in Maternal-Fetal Medicine. STUDY
DESIGN: An interactive survey of obstetric treatment was performed as part of a postgraduate course at the 2004 Annual Meeting of the Society for Maternal-Fetal Medicine. Seven controversial topics were addressed, which included tocolytic therapy, progesterone supplementation for the prevention of preterm birth, screening for inherited thrombophilia, cervical cerclage for a shortened cervix, treatment of preterm premature rupture of membranes, magnesium sulfate seizure prophylaxis, and dexamethasone therapy for HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
RESULTS: A total of 298 obstetric care providers attended the postgraduate course. By report, most attendees were maternal-fetal medicine specialists (60.7% of respondents) who were >10 years out from specialty training (56.3% of respondents) and who were practicing in a university-based setting (52.9% of respondents). An average of 233 practitioners (range, 157-298 practitioners) answered each question. An analysis of the responses allowed for the determination of current practice patterns in the 7 controversial areas addressed.
CONCLUSION: Contemporary practice patterns for 7 controversial topics in obstetric medicine are described. Such surveys may be useful in defining standards of care in maternal-fetal medicine.

Entities:  

Mesh:

Year:  2004        PMID: 15507989     DOI: 10.1016/j.ajog.2004.06.043

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  Neonatology in developed and developing nations.

Authors:  Pankaj Garg; Srinivas Bolisetty
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 1.967

2.  Magnesium sulfate exposure and neonatal intensive care unit admission at term.

Authors:  A I Girsen; M B Greenberg; Y Y El-Sayed; H Lee; B Carvalho; D J Lyell
Journal:  J Perinatol       Date:  2014-10-16       Impact factor: 2.521

3.  The matrix metalloproteases and endothelin-1 in infection-associated preterm birth.

Authors:  Nicole S Olgun; Sandra E Reznik
Journal:  Obstet Gynecol Int       Date:  2010-07-26

Review 4.  Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.

Authors:  Jaro Wex; Mark Connolly; Werner Rath
Journal:  BMC Pregnancy Childbirth       Date:  2009-06-19       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.